Horizon Kinetics Medical ETFHorizon Kinetics Medical ETFHorizon Kinetics Medical ETF

Horizon Kinetics Medical ETF

No trades

Key stats


Assets under management (AUM)
‪19.27 M‬USD
Fund flows (1Y)
‪−768.66 K‬USD
Dividend yield (indicated)
1.19%
Discount/Premium to NAV
0.03%
Shares outstanding
‪569.95 K‬
Expense ratio
0.85%

About Horizon Kinetics Medical ETF


Brand
Horizon Kinetics
Inception date
Jan 30, 2023
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Replication method
Physical
Management style
Active
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Horizon Kinetics Asset Management LLC
Distributor
Foreside Fund Services LLC
Identifiers
3
ISIN US53656G5633
MEDX aims for long-term capital growth through investments in global companies engaged in the broad healthcare sector. The portfolio may include companies of any market capitalization. Eligible securities must have at least 50% of their company revenue in medical research, pharmaceuticals, and medical technology. Such companies may include surgical & medical instrument manufacturers and biotech names. The portfolio emphasizes companies whose activities specifically involve cancer research, treatment, and pharmaceutical development. Selection and weighting are based on the advisers evaluation of a companys fundamentals, industrial position, and capital investments. During temporary periods, the fund may invest up to 100% of its assets in US short-term debt securities and money market instruments. The fund may invest up to 20% in convertibles and non-convertible high-yield bonds. The fund is actively managed and the adviser has full discretion in adjusting the portfolio.

Broaden your horizons with more funds linked to this ETF via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
73%26%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
MEDX trades at 34.27 USD today, its price has fallen −0.95% in the past 24 hours. Track more dynamics on MEDX price chart.
MEDX net asset value is 34.43 today — it's risen 2.19% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
MEDX assets under management is ‪19.27 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
MEDX price has risen by 2.96% over the last month, and its yearly performance shows a 24.74% increase. See more dynamics on MEDX price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.19% over the last month, showed a 10.79% increase in three-month performance and has increased by 25.94% in a year.
MEDX fund flows account for ‪−768.66 K‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
MEDX invests in stocks. See more details in our Analysis section.
MEDX expense ratio is 0.85%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, MEDX isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, MEDX technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating MEDX shows the buy signal. See more of MEDX technicals for a more comprehensive analysis.
Yes, MEDX pays dividends to its holders with the dividend yield of 1.19%.
MEDX trades at a premium (0.03%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
MEDX shares are issued by Horizon Kinetics Holding Corp.
MEDX follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Jan 30, 2023.
The fund's management style is active, aiming to outperform its benchmark index by actively selecting and adjusting assets. The goal is to achieve returns that exceed those of the index the fund tracks.